CD274 and nasopharyngeal carcinoma: These differences could also illustrate why the PD-L1 expression rate was found to be much lower (25%) in the NPC patients reported by Lee et al. 17 than that reported in our results (97.0%) and Zhang et al. 16 (95.0%).